문서 편집 권한이 없습니다. 다음 이유를 확인해주세요: 요청한 명령은 다음 권한을 가진 사용자에게 제한됩니다: 사용자. 문서의 원본을 보거나 복사할 수 있습니다. {|class="wikitable" style="width:100%;text-align:center;line-height:18px;word-break:keep-all;letter-spacing:-0.7px;" |- |style="font-size:20px;font-weight:700;padding:18px;background:#000;color:#fff;" colspan="3"|대한민국 코로나19 백신 접종 현황 |- |style="width:60%;font-size:28px;font-weight:700;padding:24px;"|40,513,091 |style="width:20%;font-size:20px;font-weight:700;padding:20px;"|{{#expr: 40513091 / 51671569 * 100 round 1}}% |style="width:20%;font-size:20px;font-weight:700;padding:20px;"|91.6% |- |style="padding:10px;font-weight:700;"|접종자 수 |style="padding:10px;font-weight:700;"|전국민 접종률 |style="padding:10px;font-weight:700;"|18세 이상 접종률 |- |style="font-size:16px;font-weight:700;padding:10px;background:#fff;color:#000;" colspan="1"|34,265,084 접종완료 |style="font-size:16px;font-weight:700;padding:10px;background:#1E90FF;color:#fff;"|{{#expr: 34265084 / 51671569 * 100 round 1}}% |style="font-size:16px;font-weight:700;padding:10px;background:#1E90FF;color:#fff;"|77.6% |- |style="font-size:16px;font-weight:700;padding:10px;background:#fff;color:#000;" colspan="1"|9,053 부스터샷 |style="font-size:16px;font-weight:700;padding:10px;background:#1E90FF;color:#fff;" colspan="2"|{{#expr: 9053 / 51671569 * 100 round 1}}% |- |style="font-size:12px;font-weight:400;padding:8px;background:#f7faff;" colspan="3"|2021년 10월 19일 24시 기준 <sup>[https://jumin.mois.go.kr/ageStatMonth.do 인구출처]</sup> |} == [[코로나바이러스감염증-19/백신|국내 도입 백신 종류]] == {|class="wikitable" style="width:100%;text-align:center;font-size:10px;line-height:14px;word-break:keep-all;" |- !style="background:#000;color:#fff;" colspan="2"|개발회사 !style="background:#000;color:#fff;"|백신명칭 !style="background:#000;color:#fff;"|종류 !style="background:#000;color:#fff;"|개발국 |- |colspan="5" style="text-align:center;"|'''도입 중''' |- |style="background-image:linear-gradient(45deg,#007cc2 0%,#becd32 100%);color:white;"|Pfizer/BioNTech |화이자/바이오엔테크 |[[토지나메란|BNT162b2]] |mRNA |[[미국]]/[[독일]] |- |style="background-image:linear-gradient(45deg,#002147 0%,#860052 100%);color:white;"|Oxford/AstraZeneca |옥스포드/아스트라제네카 |[[AZD1222]] |바이러스벡터 |[[영국]]/[[스웨덴]] |- |style="background:#e71538;color:white;"|Moderna |모더나 |mRNA-1273 |mRNA |[[미국]] |- |style="background:#d51900;color:white;"|Johnson & Johnson(Janssen) |존슨앤존슨(얀센) |Ad26.COV2.S |바이러스벡터 |[[미국]] |- |colspan="5" style="text-align:center;"|'''도입 전''' |- |style="background:#13518c;color:white;"|Novavax |노바백스 |CoV2373 |바이러스벡터 |[[미국]] |- |colspan="5" style="text-align:left;background:#f7faff;"|자료출처: [https://covid19.trackvaccines.org/country/south-korea/ COVID19 Vaccine Tracker] |} 전세계 백신 계약 현황은 [[코로나바이러스감염증-19/백신/국가별 계약]] 문서 참조. == 접종 계획 == * '''대상군별 접종 순서''' {|class="wikitable" style="width:100%;text-align:center;font-size:11px;line-height:16px;" |- !style="background:#013668;color:white;"|그룹 !style="background:#013668;color:white;"|목표 !style="background:#013668;color:white;"|대상군 |- |rowspan="5"|'''가''' |rowspan="5"|중증 및 사망 예방 |style="text-align:left;"|① 노인 집단시설 입소자, 종사자 |- |style="text-align:left;"|② 노인 재가복지시설 이용자, 입소자 |- |style="text-align:left;"|③ 65세 이상 |- |style="text-align:left;"|④ 성인 만성질환자 |- |style="text-align:left;"|⑤ 성인 50∼64세 |- |rowspan="5"|'''나''' |rowspan="5"|의료·방역,사회 필수기능 유지 |style="text-align:left;"|① 코로나19 환자를 치료하는 의료기관 종사자 |- |style="text-align:left;"|② 고위험 의료기관 종사자(보건의료인) |- |style="text-align:left;"|③ 1차 대응요원 |- |style="text-align:left;"|④ 의료기관 및 약국 종사자(보건의료인) |- |style="text-align:left;"|⑤ 군인, 경찰, 소방공무원, 사회 기반시설 종사자 |- |rowspan="3"|'''다''' |rowspan="3"|지역사회 전파(집단 감염) 차단 |style="text-align:left;"|① 집단시설 생활자(노인 이외) 및 종사자 |- |style="text-align:left;"|② 소아, 청소년 교육, 보육시설 종사자 |- |style="text-align:left;"|③ 성인 18∼49세 |- |rowspan="2"|'''라''' |rowspan="2"|접종 제외<br>(임상 결과에 따라 추가 가능) |style="text-align:left;"|① 소아·청소년 |- |style="text-align:left;"|② 임신부 |- |colspan="3" style="text-align:left;background:#f7faff;"|자료출처: [http://ncv.kdca.go.kr/content/plan_01_01.html 질병관리청] |} * '''대상군별 접종 시기'''<ref>백신 공급 물량에 따라 변동 가능</ref> {|class="wikitable" style="width:100%;text-align:center;font-size:10px;line-height:14px;" |- !style="width:8%;background:#013668;color:white;"|시기 !style="width:23%;background:#013668;color:white;"|1분기 !style="width:23%;background:#013668;color:white;"|2분기 !style="width:23%;background:#013668;color:white;"|3분기 !style="width:23%;background:#013668;color:white;"|4분기 |- |style="background:#f7faff;color:#405985;"| |style="background:#f7faff;color:#405985;"|'''130만명''' |style="background:#f7faff;color:#405985;"|'''900만명''' |style="background:#f7faff;color:#405985;" colspan="2"|'''3325만명''' |- |'''가군''' |style="text-align:left;"|요양병원 · 요양시설 입원 · 입소자, 종사자 |style="text-align:left;"|노인재가복지시설 이용자 · 종사자<br>65세 이상<br>(고령자부터 순차 접종) |style="text-align:left;"|성인 만성질환자<br>성인 50∼64세 |style="text-align:left;" rowspan="3"|2차 접종자,미접종자 또는 재접종자<br>(항체유지기간 고려) |- |'''나군''' |style="text-align:left;"|코로나19 환자를 치료하는 기관 종사자고위험 의료기관종사자(보건의료인)<br>1차 대응요원(역학조사 · 구급대 등) |style="text-align:left;"|의료기관 및 약국 종사자<br>(보건의료인)<br>(1분기 접종대상 外) |style="text-align:left;"|군인, 경찰, 소방 및 사회 기반시설 종사자 |- |'''다군''' |style="text-align:left;"|정신요양 · 재활시설등 입소자 · 종사자 |style="text-align:left;"|장애인·노숙인 등 시설 입소자 · 종사자 |style="text-align:left;"|소아, 청소년 교육, 보육시설 종사자<br>성인 18∼49세 |- |- |colspan="5" style="text-align:left;background:#f7faff;"|자료출처: [http://ncv.kdca.go.kr/content/plan_01_01.html 질병관리청] |} === 상반기 === {|class="wikitable" style="width:100%;text-align:center;font-size:10px;line-height:14px;" |- !style="background:#013668;color:white;"|개시일 !style="background:#013668;color:white;"|접종대상 !style="background:#013668;color:white;"|대상자 !style="background:#013668;color:white;"|백신 |- |02-26 |요양병원(65세 미만) |209,597 |옥스포드/아스트라제네카 |- |02-26 |요양시설(65세 미만) |110,961 |옥스포드/아스트라제네카 |- |02-27 |코로나치료병원 |64,339 |화이자/바이오엔테크 |- |03-03 |1차 대응요원 |78,829 |옥스포드/아스트라제네카 |- |03-04 |병원급 이상 의료기관<ref>정신 의료기관 포함, 정신 의료기관은 정신건강의학과 폐쇄병동 입원환자 포함.</ref> |389,378 |옥스포드/아스트라제네카 |- |03-23 |요양병원(65세 이상) |207,628 |옥스포드/아스트라제네카 |- |03-23 |요양시설(65세 이상) |169,913 |옥스포드/아스트라제네카 |- |04-01 |75세 이상 어르신 |3,639,517 |화이자/바이오엔테크 |- |04-01 |노인시설 거주·이용·종사자 |157,668 |화이자/바이오엔테크 |- |04-08 |특수교육·보육, 보건교사 및 어린이집 간호인력 |64,360 |옥스포드/아스트라제네카 |- |04-09 |장애인 시설 |62,992 |옥스포드/아스트라제네카 |- |04-09 |노인요양공동생활가정 |26,726 |옥스포드/아스트라제네카 |- |04-09 |결핵 및 한센인 거주시설 |386 |옥스포드/아스트라제네카 |- |04-09 |노숙인 거주 및 이용시설 |17,529 |옥스포드/아스트라제네카 |- |04-12 |교정시설 등 종사자 |20,089 |옥스포드/아스트라제네카 |- |04-19 |항공승무원 |26,850 |옥스포드/아스트라제네카 |- |04-19 |장애인 및 노인돌봄 종사자 |383,259 |옥스포드/아스트라제네카 |- |04-26 |보건의료인(의원급의료기관·약국) |294,000 |옥스포드/아스트라제네카 |- |04-26 |만성신장질환자(투석환자) |78,000 |옥스포드/아스트라제네카 |- |04-26 |사회필수인력(30세 이상) |177,000 |옥스포드/아스트라제네카 |- |04-28 |사회필수인력(30세 이상 군인) |126,000 |옥스포드/아스트라제네카 |- |05-27 |만성중증호흡기질환자 |7,900 |옥스포드/아스트라제네카 |- |05-27 |70~74세 |2,131,274 |옥스포드/아스트라제네카 |- |05-27 |65~69세 |2,989,177 |옥스포드/아스트라제네카 |- |06-07 |60~64세 |3,924,344 |옥스포드/아스트라제네카 |- |06-07 |유치원·어린이집, 초등교사(돌봄인력) 등 |342,589 |화이자/바이오엔테크, 모더나 |- |06-07 |30세 미만 군 장병 |414,000 |화이자/바이오엔테크 |- |06-10 |예비군·민방위, 국방·외교 관련(30세 이상) | |얀센 |- |06-17 |병원급 이상 의료기관(30세 미만) | |모더나 |- |colspan="2"|상반기 |colspan="2"|1400만명 목표 |- |colspan="5" style="text-align:left;background:#f7faff;"|자료출처: [http://ncv.kdca.go.kr/content/plan_01_01.html 질병관리청] |} === 하반기 === {|class="wikitable" style="width:100%;text-align:center;font-size:10px;line-height:14px;letter-spacing:-0.2px;" |- !style="background:#f7faff;color:#405985;" rowspan="9"|7월 |style="text-align:left;"|'''60∼74세 등 6월 예약자 중 미접종자'''<br>7.5~7.17 |19.7만명 |화이자/바이오엔테크 |- |style="text-align:left;"|'''30세 미만 사회필수인력 등 6월 예약자 중 미접종자'''<br>7.5~7.17 |11만명 |화이자/바이오엔테크 |- |style="text-align:left;"|'''7∼9월 중 입영 예정자'''<br>7.12~ |7만명 |화이자/바이오엔테크 |- |style="text-align:left;"|'''유치원 및 초등 1·2학년 교직원 및 돌봄인력'''<br>7.13~7.17 |38만명 |화이자/바이오엔테크 |- |style="text-align:left;"|'''고3·고교 교직원'''<br>7.19~7.30 |64만명 |화이자/바이오엔테크 |- |style="text-align:left;"|'''60∼74세 중 예약취소·접종연기자'''<br>7.26~7.31 |10만명 |모더나 |- |style="text-align:left;"|'''사업장 종사자'''<br>7.27~ |30.3만명 |화이자/바이오엔테크 |- |style="text-align:left;"|'''교육·보육인력, 돌봄인력'''<br>7.28~ |89.5만명 |화이자/바이오엔테크 |- |style="text-align:left;"|'''55∼59세'''<br>7.26∼ |352.4만명 |화이자/바이오엔테크, 모더나 |- !style="background:#f7faff;color:#405985;" rowspan="4"|8월 |style="text-align:left;"|'''50∼54세'''<br>8.16∼ |390만명 |화이자/바이오엔테크, 모더나 |- |style="text-align:left;"|'''기타 대입수험생'''<br>8.10~8.14 |15만명 |화이자/바이오엔테크 |- |style="text-align:left;"|'''18~49세 지자체 자율접종'''<br>8.17~9.11 |200만명 |화이자/바이오엔테크, 모더나 |- |style="text-align:left;"|'''18~49세'''<br>8.26~10.2 |1777.3만명 |화이자/바이오엔테크, 모더나 |- !style="background:#f7faff;color:#405985;" rowspan="4"|10월 |style="text-align:left;"|'''만 18세 이상 미접종자(사전예약)'''<br>10.1∼10.16 | |화이자/바이오엔테크, 모더나 |- |style="text-align:left;"|'''만 18세 이상 미접종자(현장접수 또는 잔여백신)'''<br>10.1∼10.16 | |아스트라제네카, 얀센 |- |style="text-align:left;"|'''16∼17세'''<br>10.18∼11.13 | |화이자/바이오엔테크 |- |style="text-align:left;"|'''임신부'''<br>10.18∼11.13 | |화이자/바이오엔테크, 모더나 |- !style="background:#f7faff;color:#405985;"|11월 |style="text-align:left;"|'''12∼15세'''<br>11.1~11.27 | |화이자/바이오엔테크 |- |colspan="4" style="text-align:left;background:#f7faff;"|자료출처: [http://ncv.kdca.go.kr/content/plan_01_01.html 질병관리청] |} * '''부스터샷(추가접종)''' {|class="wikitable" style="width:100%;text-align:center;font-size:10px;line-height:14px;letter-spacing:-0.2px;" |- !style="background:#f7faff;color:#405985;" rowspan="2"|10월 |style="text-align:left;"|'''코로나19 치료병원 종사자'''<br>10.12∼11.30 |6만명 |화이자/바이오엔테크 |- |style="text-align:left;"|'''60세 이상 고령층 및 그 외 고위험군'''<br>10.25~ |4분기<br>279만명 |화이자/바이오엔테크, 모더나 |- !style="background:#f7faff;color:#405985;" rowspan="3"|11월 |style="text-align:left;"|'''면역저하자'''<br>11.1~ | |화이자/바이오엔테크, 모더나 |- |style="text-align:left;"|'''요양병원·시설의 입원·입소·종사자'''<br>11.10~ |50만명 |화이자/바이오엔테크, 모더나 |- |style="text-align:left;"|'''병원급 이상 의료기관 종사자'''<br>11.15~ |34만명 |화이자/바이오엔테크, 모더나 |- !style="background:#f7faff;color:#405985;" rowspan="1"|12월 |style="text-align:left;"|'''사회필수인력을 포함한 일반 국민'''<br>12월 | | |} == 백신 개발·계약 현황 == * '''국내 백신 개발 현황 ''' {|class="wikitable" style="width:100%;text-align:center;font-size:10px;line-height:14px;" |- !style="background:#013668;color:white;"|개발회사 !style="background:#013668;color:white;"|개발명 !style="background:#013668;color:white;"|종류 !style="background:#013668;color:white;"|승인일 !style="background:#013668;color:white;"|현황 |- |SK바이오사이언스 |NBP2001 |합성항원 |2020-11-23 |1상 |- |rowspan="2"|셀리드 |AdCLD-CoV19 |바이러스벡터 |2020-12-04 |1/2상 |- |AdCLD-CoV19-1 |바이러스벡터 |2021-07-23 |1상 |- |진원생명과학 |GLS-5310 |DNA |2020-12-04 |1/2a상 |- |rowspan="2"|제넥신 |rowspan="2"|GX-19 |rowspan="2"|DNA |2020-12-11 |1/2a상 |- |2021-01-29 |1상 |- |SK바이오사이언스 |GBP510<br><sub>면역증강제: 알루미늄</sub> |합성항원 |2020-12-31 |1/2상 |- |유바이오로직스 |유코백-19<br><sub>EuCorVac-19</sub> |합성항원 |2021-01-20 |1/2상 |- |rowspan="2"|SK바이오사이언스 |rowspan="2"|GBP510<br><sub>면역증강제: AS03</sub> |rowspan="2"|합성항원 |2021-01-26 |1/2상 |- |2021-08-10 |'''3상''' |- |(주)큐라티스 |QTP104 |RNA |2021-07-19 |1상 |- |에이치케이이노엔(주) |IN-B009주 |합성항원 |2021-07-22 |1상 |- |아이진(주) |EG-COVID |RNA |2021-08-31 |1/2a상 |- |colspan="5" style="text-align:left;background:#f7faff;"|자료출처: [https://covid19.trackvaccines.org/country/south-korea/ COVID19 Vaccine Tracker] [https://www.mfds.go.kr/vaccine_covid19.jsp 식품의약품안전처] |} * '''국내 백신 계약 현황''' {|class="wikitable" style="width:100%;text-align:center;font-size:10px;line-height:14px;" |- !style="background:#013668;color:white;"|날짜 !style="background:#013668;color:white;"|개발회사 !style="background:#013668;color:white;"|계약물량 !style="background:#013668;color:white;"|계약국가 |- |2021-04-27 |제넥신 |1천만 회분 |인도네시아 |- |} == 생산·수출 현황 == === 백신 국내 생산 현황 === {|class="wikitable" style="width:100%;text-align:center;font-size:10px;line-height:14px;" |- !style="background:#013668;color:white;"|백신종류 !style="background:#013668;color:white;"|생산업체 !style="background:#013668;color:white;"|생산량 !style="background:#013668;color:white;"|상태 |- |Oxford/AstraZeneca |SK바이오사이언스 | |생산중 |- |Sputnik V |한국코러스 컨소시엄<ref>한국코러스(지엘라파), 바이넥스, 이수앱지스, 보령바이오파마, 종근당바이오, 큐라티스, 휴메딕스, 안동 동물세포실증지원센터 등 8곳.</ref> |6억5천만 회분 | |- |Sputnik V |휴온스 컨소시엄<ref>휴온스글로벌, 프레스티지바이오파마, 휴메딕스, 보람파마 등 4곳.</ref> |12억 회분<sup>추정</sup> | |- |Novavax |SK바이오사이언스 |국내 4천만 회분<ref>국내 도입 예정 물량</ref> |생산중 |- |Moderna |삼성바이오로직스 |패키징/협의중 |계약진행 |- |colspan="4" style="text-align:left;background:#f7faff;"|*생산량은 기업, 국가간 계약 및 상황에 따라 유동적. |} === 백신 국외 수출 현황 === 본 자료는 모든 데이터를 포함하지 않고 있으며, 언론 보도 내용에 따라 일부 부정확할 수 있습니다. {|class="wikitable" style="width:100%;text-align:center;font-size:10px;line-height:14px;letter-spacing:-0.5px;word-break:keep-all;" |- !style="background:#013668;color:white;"|날짜 !style="background:#013668;color:white;"|백신종류 !style="background:#013668;color:white;"|생산업체 !style="background:#013668;color:white;"|수출량 !style="background:#013668;color:white;"|수출국가 !style="background:#013668;color:white;"|근거자료 |- |style="min-width:70px;"|2020-12-29 |Sputnik V |지엘라파 | |러시아 |[https://www.yna.co.kr/view/AKR20201229035900003] |- |2021-02-23 |Oxford/AstraZeneca |SK바이오사이언스 |11만7천6백도즈 |베트남 |[https://scandasia.com/first-batch-of-covid-19-vaccine-by-astrazeneca-arrived-vietnam-and-thailand/] |- |2021-02-24 |Oxford/AstraZeneca |SK바이오사이언스 |11만7천6백도즈 |태국 |[https://scandasia.com/first-batch-of-covid-19-vaccine-by-astrazeneca-arrived-vietnam-and-thailand/] |- |2021-03-04 |Oxford/AstraZeneca |SK바이오사이언스 |11만7천도즈 |대만 |[https://www.taiwannews.com.tw/ch/news/4140793] |- |2021-03-06 |Oxford/AstraZeneca |SK바이오사이언스 |1만2천도즈 |피지 |[http://www.worldkorean.net/news/articleView.html?idxno=39010] |- |2021-03-21 |Oxford/AstraZeneca |SK바이오사이언스 |102만2천4백도즈 |브라질 |[https://www.unicef.org/lac/en/press-releases/brazil-will-receive-first-vaccines-against-covid-19-through-covax-mechanism-sunday] |- |2021-04-05 |Oxford/AstraZeneca |SK바이오사이언스 |70만도즈 |이란 |[http://naver.me/5JJZNAlV] |- |2021-04-07 |Oxford/AstraZeneca |SK바이오사이언스 |19만9천2백도즈 |대만 |[http://naver.me/Fa3tM3Ga] |- |2021-05-19 |Oxford/AstraZeneca |SK바이오사이언스 |40만1천도즈 |대만 |[https://www.reuters.com/world/asia-pacific/taiwan-calls-fair-access-vaccines-amid-covid-spike-2021-05-19/] |- |colspan="6" style="text-align:left;background:#f7faff;"|각국 언론 보도 자료 종합 |} == 도입 현황 == === 백신 품목 심사 정보 === {|class="wikitable" style="width:100%;text-align:center;font-size:10px;line-height:14px;" |- !style="background:#013668;color:white;"|업체명 !style="background:#013668;color:white;"|제품명 !style="background:#013668;color:white;"|플랫폼 !style="background:#013668;color:white;"|진행상황 |- |colspan="5" style="background:#f7faff;"|허가완료 |- |한국아스트라제네카(주) |한국아스트라제네카 코비드-19백신주 |바이러스벡터 |허가완료<br>2021-02-10 |- |한국화이자(주) |코미나티주(토지나메란) |RNA |허가완료<br>2021-03-05 |- |(주)한국얀센 |코비드-19백신얀센주 |바이러스벡터 |허가완료<br>2021-04-07 |- |(주)녹십자 |모더나코비드-19 백신주 |mRNA |허가완료<br>2021-05-21 |- |한국아스트라제네카(주) |아스트라제네카 코비드-19백신주<sub>(수입)</sub> |바이러스벡터 |허가완료<br>2021-05-21 |- |colspan="5" style="background:#f7faff;"|허가신청 |- |colspan="5" style="background:#f7faff;"|사전검토 |- |에스케이바이오사이언스(주) |사스코로나바이러스-2 재조합스파이크단백질나노파티클백신 |재조합 백신 |신청일<br>2021-04-29 |- |(주)휴온스 |스푸트니크V주 |바이러스벡터 백신 |신청일<br>2021-04-29 |- |colspan="5" style="text-align:left;background:#f7faff;"|자료출처: [https://www.mfds.go.kr/vaccine_covid19.jsp 식품의약품안전처] |} === 도입 완료 === {|class="wikitable" style="width:100%;text-align:center;font-size:10px;line-height:14px;padding:0px;" |- !style="background:#013668;color:white;"|도입일 !style="background:#013668;color:white;"|백신종류 !style="background:#013668;color:white;"|도입규모(회분) !style="background:#013668;color:white;"|분량(명) |- |2021-02-17 |Oxford/AstraZeneca |1574000 |787000 |- |2021-02-26 |Pfizer/BioNTech<sup>COVAX</sup> |117000 |58500 |- |2021-03-24 |Pfizer/BioNTech |500000 |250000 |- |2021-03-31 |Pfizer/BioNTech |500000 |250000 |- |2021-04-03 |Oxford/AstraZeneca<sup>COVAX</sup> |432000 |216000 |- |2021-04-05 |Pfizer/BioNTech |250000 |125000 |- |2021-04-14 |Pfizer/BioNTech |250000 |125000 |- |2021-04-21 |Pfizer/BioNTech |250000 |125000 |- |2021-04-28 |Pfizer/BioNTech |250000 |125000 |- |2021-05-05 |Pfizer/BioNTech |436000 |218000 |- |2021-05-12 |Pfizer/BioNTech |438000 |219000 |- |2021-05-13 |Oxford/AstraZeneca<sup>COVAX</sup> |835000 |417500 |- |2021-05-14 |Oxford/AstraZeneca |597000 |248500 |- |2021-05-17 |Oxford/AstraZeneca |1068000 |534000 |- |2021-05-19 |Pfizer/BioNTech |438000 |219000 |- |2021-05-21 |Pfizer/BioNTech<sup>COVAX</sup> |297000 |148500 |- |2021-05-23 |Pfizer/BioNTech |438000 |219000 |- |2021-05-25 |Oxford/AstraZeneca |1068000 |534000 |- |2021-05-27 |Oxford/AstraZeneca |1069000 |534500 |- |2021-05-28 |Oxford/AstraZeneca |828000 |414000 |- |2021-06-01 |Oxford/AstraZeneca |879000 |439500 |- |2021-06-01 |Moderna |54700 |27350 |- |2021-06-02 |Pfizer/BioNTech |650000 |325000 |- |2021-06-03 |Oxford/AstraZeneca |853000 |426500 |- |2021-06-04 |Oxford/AstraZeneca |877000 |438500 |- |2021-06-05 |Johnson & Johnson<sup>US</sup> |1012800 |1012800 |- |2021-06-09 |Pfizer/BioNTech |650000 |325000 |- |2021-06-16 |Pfizer/BioNTech |650000 |325000 |- |2021-06-23 |Pfizer/BioNTech |650000 |325000 |- |2021-06-24 |Moderna |56000 |28000 |- |2021-06-30 |Pfizer/BioNTech |650000 |325000 |- |2021-07-07 |Pfizer/BioNTech |627000 |313500 |- |2021-07-07 |Pfizer/BioNTech<sup>백신스와프</sup> |700000 |350000 |- |2021-07-08 |Moderna |354000 |177000 |- |2021-07-12 |Moderna |396000 |198000 |- |2021-07-14 |Pfizer/BioNTech |799000 |399500 |- |2021-07-18 |Oxford/AstraZeneca |1188000 |594000 |- |2021-07-21 |Pfizer/BioNTech |1866000 |933000 |- |2021-07-21 |Pfizer/BioNTech<sup>백신스와프</sup> |81000 |40500 |- |2021-07-22 |Moderna |290000 |145000 |- |2021-07-28 |Pfizer/BioNTech |2679000 |1339500 |- |2021-07-29 |Johnson & Johnson |101000 |101000 |- |2021-08-03 |Oxford/AstraZeneca |1182000 |591000 |- |2021-08-04 |Pfizer/BioNTech |2530000 |1265000 |- |2021-08-04 |Oxford/AstraZeneca |1188000 |594000 |- |2021-08-05 |Oxford/AstraZeneca |1185000 |592500 |- |2021-08-07 |Moderna |1303000 |651500 |- |2021-08-11 |Pfizer/BioNTech |1600000 |800000 |- |2021-08-13 |Oxford/AstraZeneca |1028000 |514000 |- |2021-08-15 |Johnson & Johnson<sup>US</sup> |400000 |400000 |- |2021-08-17 |Oxford/AstraZeneca |1100000 |550000 |- |2021-08-18 |Oxford/AstraZeneca |1036000 |518000 |- |2021-08-18 |Pfizer/BioNTech |1601000 |800500 |- |2021-08-19 |Oxford/AstraZeneca |1041000 |520500 |- |2021-08-23 |Moderna |1017000 |508500 |- |2021-08-25 |Pfizer/BioNTech |1599000 |799500 |- |2021-08-26 |Oxford/AstraZeneca<sup>COVAX</sup> |835000 |417500 |- |2021-08-27 |Oxford/AstraZeneca |1046000 |523000 |- |2021-08-31 |Oxford/AstraZeneca |1192000 |596000 |- |2021-09-01 |Pfizer/BioNTech |2682000 |1341000 |- |2021-09-02 |Pfizer/BioNTech<sup>루마니아</sup> |526500 |263250 |- |2021-09-02 |Moderna |1021000 |510500 |- |2021-09-03 |Moderna |905000 |452500 |- |2021-09-05 |Moderna |1263000 |631500 |- |2021-09-06 |Moderna |2553000 |1276500 |- |2021-09-07 |Moderna |1393000 |696500 |- |2021-09-08 |Pfizer/BioNTech |3428000 |1714000 |- |2021-09-08 |Pfizer/BioNTech<sup>루마니아</sup> |526500 |263250 |- |2021-09-08 |Moderna<sup>루마니아</sup> |450000 |225000 |- |2021-09-09 |Moderna |873000 |436500 |- |2021-09-15 |Pfizer/BioNTech |1302000 |651000 |- |2021-09-17 |Moderna |871000 |435500 |- |2021-09-20 |Pfizer/BioNTech |2843000 |1421500 |- |2021-09-22 |Pfizer/BioNTech |4625000 |2312500 |- |2021-09-25 |Moderna |1071000 |535500 |- |2021-10-02 |Moderna |1375000 |687500 |- |2021-10-02 |Pfizer/BioNTech<sup>루마니아</sup> |436000 |218000 |- |2021-10-06 |Pfizer/BioNTech |442000 |221000 |- |2021-10-07 |Pfizer/BioNTech<sup>UK</sup> |97000 |48500 |- |2021-10-07 |Moderna |2629000 |1314500 |- |2021-10-08 |Pfizer/BioNTech<sup>UK</sup> |468000 |234000 |- |2021-10-13 |Pfizer/BioNTech |136000 |68000 |- |2021-10-15 |Pfizer/BioNTech<sup>UK</sup> |469000 |234500 |- |2021-10-16 |Pfizer/BioNTech |1369000 |684500 |- |2021-10-17 |Pfizer/BioNTech |1404000 |702000 |- |2021-10-18 |Pfizer/BioNTech |1081000 |540500 |- |2021-10-20 |Pfizer/BioNTech |2678000 |1339000 |- |colspan="2"|'''합계''' |'''87,469,000''' |'''44,502,900''' |- |colspan="4" style="text-align:left;background:#f7faff;"|COVAX: 코백스 퍼실리티(COVAX Facility)를 통해 도입된 백신<br>백신스와프: 국가간 백신 스와프 협정으로 도입된 백신<br>US: 미국 정부 공여 백신<br>자료출처: [http://ncov.mohw.go.kr 질병관리청] |} {|class="wikitable" style="width:100%;text-align:center;font-size:10px;line-height:14px;padding:0px;" |- !style="background:#013668;color:white;"|최초도입일 !style="background:#013668;color:white;"|백신종류 !style="background:#013668;color:white;"|누적도입량(회분) !style="background:#013668;color:white;"|누적도입량(명) |- |2021-02-17 |Oxford/AstraZeneca |22,101,000 |11,050,500 |- |2021-02-26 |Pfizer/BioNTech |46,009,000 |23,004,500 |- |2021-06-01 |Moderna |17,574,700 |8,787,350 |- |2021-06-05 |Johnson & Johnson |1,513,800 |1,513,800 |- |} === 백신 잔여량 === {|class="wikitable" style="width:100%;text-align:center;font-size:10px;line-height:14px;padding:0px;" |- !style="background:#013668;color:white;"|최초도입일 !style="background:#013668;color:white;"|백신종류 !style="background:#013668;color:white;"|백신 잔여량(천 회분) |- |2021-02-17 |Oxford/AstraZeneca |2,309.0 |- |2021-02-26 |Pfizer/BioNTech |6,674.8 |- |2021-06-01 |Moderna |8,098.2 |- |2021-06-05 |Johnson & Johnson |200.7 |- |colspan="2"|'''총계''' |17,282.7 |- |} * '''질병관리청, 10월 19일 기준''' : 상기통계자료는 지역예방접종센터 등의 예방접종등록 상황에 따라 변동 가능한 잠정 통계임 === 도입 예정 === {|class="wikitable" style="width:100%;text-align:center;font-size:10px;line-height:14px;" |- !style="background:#013668;color:white;"|최초도입 !style="background:#013668;color:white;"|백신종류 !style="background:#013668;color:white;"|도입규모(회분) !style="background:#013668;color:white;"|분량(명) |- |9월 | |5천만 회분 |예정 |- |4분기 | |9천만 회분 |예정 |- |colspan="4" style="text-align:center;background:#f7faff;"|백신 계약 현황 및 첫 도입 시기 |- |1분기 |국제백신공급기구(COVAX)<ref>백신 종류 다수</ref> |colspan="2"|1천만명 분 |- |1분기 |'''Oxford/AstraZeneca''' <sup>도입완료</sup> |colspan="2"|1천만명 분 |- |1분기 |Pfizer/BioNTech |colspan="2"|3천3백만명 분 |- |2분기 |Johnson & Johnson(Janssen) |colspan="2"|6백만명 분 |- |2분기 |Moderna |colspan="2"|2천만명 분 |- |미정 |Novavax<ref>전량 국내생산</ref> |colspan="2"|2천만명 분 |- |colspan="4" style="text-align:left;background:#f7faff;"|COVAX: 코백스 퍼실리티(COVAX Facility)를 통해 도입 예정인 백신<br>자료출처: [http://ncov.mohw.go.kr 질병관리청] |} == 접종 현황 == * '''2021년 10월 19일 24시 기준''' === 종합 === * '''[[코로나바이러스감염증-19/백신/대한민국/접종센터|접종센터 운영 현황]]''' {|class="wikitable" style="width:100%;text-align:center;font-size:10px;line-height:14px;" |- !style="background:#013668;color:white;"|구분 !style="background:#013668;color:white;"|접종백신 !style="background:#013668;color:white;"|개소 |- |예방접종센터 |Pfizer/BioNTech |266 |- |위탁의료기관 |Oxford/AstraZeneca, Janssen |12,957 |- |} : 자세한 내용은 [[코로나바이러스감염증-19/백신/대한민국/접종센터|해당문서]] 참조. * '''일일 접종 현황''' ==== 1분기 ==== {|class="wikitable" style="width:100%;text-align:center;font-size:10px;line-height:12px;letter-spacing:-0.5px;" |- !style="background:#013668;color:white;"|날짜 !style="background:#013668;color:white;"|접종 백신 !style="background:#013668;color:white;"|1회차 접종 !style="background:#013668;color:white;"|접종 완료 |- |2021-02-26 |Oxford/AstraZeneca |18489 |0 |- |2021-02-27 |Oxford/AstraZeneca, Pfizer/BioNTech |20322 |0 |- |2021-02-28 |Oxford/AstraZeneca, Pfizer/BioNTech |21177 |0 |- |style="background:#f7faff;"|2021-03-01 |Oxford/AstraZeneca, Pfizer/BioNTech |23086 |0 |- |2021-03-02 |Oxford/AstraZeneca, Pfizer/BioNTech |87428 |0 |- |2021-03-03 |Oxford/AstraZeneca, Pfizer/BioNTech |154421 |0 |- |2021-03-04 |Oxford/AstraZeneca, Pfizer/BioNTech |225853 |0 |- |2021-03-05 |Oxford/AstraZeneca, Pfizer/BioNTech |296380 |0 |- |2021-03-06 |Oxford/AstraZeneca, Pfizer/BioNTech |314656 |0 |- |2021-03-07 |Oxford/AstraZeneca, Pfizer/BioNTech |316865 |0 |- |2021-03-08 |Oxford/AstraZeneca, Pfizer/BioNTech |383346 |0 |- |2021-03-09 |Oxford/AstraZeneca, Pfizer/BioNTech |446941 |0 |- |2021-03-10 |Oxford/AstraZeneca, Pfizer/BioNTech |500635 |0 |- |2021-03-11 |Oxford/AstraZeneca, Pfizer/BioNTech |546277 |0 |- |2021-03-12 |Oxford/AstraZeneca, Pfizer/BioNTech |583658 |0 |- |2021-03-13 |Oxford/AstraZeneca, Pfizer/BioNTech |587884 |0 |- |2021-03-14 |Oxford/AstraZeneca, Pfizer/BioNTech |588958 |0 |- |2021-03-15 |Oxford/AstraZeneca, Pfizer/BioNTech |602150 |0 |- |2021-03-16 |Oxford/AstraZeneca, Pfizer/BioNTech |621734 |0 |- |2021-03-17 |Oxford/AstraZeneca, Pfizer/BioNTech |641331 |0 |- |2021-03-18 |Oxford/AstraZeneca, Pfizer/BioNTech |659475 |0 |- |2021-03-19 |Oxford/AstraZeneca, Pfizer/BioNTech |675426 |0 |- |2021-03-20 |Oxford/AstraZeneca, Pfizer/BioNTech |676587 |313 |- |2021-03-21 |Oxford/AstraZeneca, Pfizer/BioNTech |676607 |593 |- |2021-03-22 |Oxford/AstraZeneca, Pfizer/BioNTech |680560 |883 |- |2021-03-23 |Oxford/AstraZeneca, Pfizer/BioNTech |703612 |1498 |- |2021-03-24 |Oxford/AstraZeneca, Pfizer/BioNTech |733124 |2691 |- |2021-03-25 |Oxford/AstraZeneca, Pfizer/BioNTech |767451 |3833 |- |2021-03-26 |Oxford/AstraZeneca, Pfizer/BioNTech |792274 |5232 |- |2021-03-27 |Oxford/AstraZeneca, Pfizer/BioNTech |793858 |5232 |- |2021-03-28 |Oxford/AstraZeneca, Pfizer/BioNTech |793966 |5232 |- |2021-03-29 |Oxford/AstraZeneca, Pfizer/BioNTech |822448 |6151 |- |2021-03-30 |Oxford/AstraZeneca, Pfizer/BioNTech |852202 |8185 |- |2021-03-31 |Oxford/AstraZeneca, Pfizer/BioNTech |876573 |12973 |- |} ==== 2분기 ==== {|class="wikitable" style="width:100%;text-align:center;font-size:10px;line-height:12px;letter-spacing:-0.5px;" |- !style="background:#013668;color:white;"|날짜 !style="background:#013668;color:white;"|접종 백신 !style="background:#013668;color:white;"|1회차 접종 !style="background:#013668;color:white;"|접종 완료 |- |style="background:#f7faff;min-width:64px;"|2021-04-01 |Oxford/AstraZeneca, Pfizer/BioNTech |914069 |19855 |- |2021-04-02 |Oxford/AstraZeneca, Pfizer/BioNTech |953556 |26380 |- |2021-04-03 |Oxford/AstraZeneca, Pfizer/BioNTech |962083 |27298 |- |2021-04-04 |Oxford/AstraZeneca, Pfizer/BioNTech |962730 |27364 |- |2021-04-05 |Oxford/AstraZeneca, Pfizer/BioNTech |999870 |27691 |- |2021-04-06 |Oxford/AstraZeneca, Pfizer/BioNTech |1039066 |33414 |- |2021-04-07 |Oxford/AstraZeneca, Pfizer/BioNTech |1075574 |42647 |- |2021-04-08 |Oxford/AstraZeneca, Pfizer/BioNTech |1113666 |52136 |- |2021-04-09 |Oxford/AstraZeneca, Pfizer/BioNTech |1148060 |59422 |- |2021-04-10 |Oxford/AstraZeneca, Pfizer/BioNTech |1156950 |60510 |- |2021-04-11 |Oxford/AstraZeneca, Pfizer/BioNTech |1157255 |60511 |- |2021-04-12 |Oxford/AstraZeneca, Pfizer/BioNTech |1195342 |60557 |- |2021-04-13 |Oxford/AstraZeneca, Pfizer/BioNTech |1239065 |60567 |- |2021-04-14 |Oxford/AstraZeneca, Pfizer/BioNTech |1285909 |60569 |- |2021-04-15 |Oxford/AstraZeneca, Pfizer/BioNTech |1379653 |60571 |- |2021-04-16 |Oxford/AstraZeneca, Pfizer/BioNTech |1482969 |60577 |- |2021-04-17 |Oxford/AstraZeneca, Pfizer/BioNTech |1512503 |60585 |- |2021-04-18 |Oxford/AstraZeneca, Pfizer/BioNTech |1517390 |60585 |- |2021-04-19 |Oxford/AstraZeneca, Pfizer/BioNTech |1639490 |60586 |- |2021-04-20 |Oxford/AstraZeneca, Pfizer/BioNTech |1771407 |60597 |- |2021-04-21 |Oxford/AstraZeneca, Pfizer/BioNTech |1903767 |60622 |- |2021-04-22 |Oxford/AstraZeneca, Pfizer/BioNTech |2035549 |79151 |- |2021-04-23 |Oxford/AstraZeneca, Pfizer/BioNTech |2195492 |98767 |- |2021-04-24 |Oxford/AstraZeneca, Pfizer/BioNTech |2260639 |104538 |- |2021-04-25 |Oxford/AstraZeneca, Pfizer/BioNTech |2266888 |104905 |- |2021-04-26 |Oxford/AstraZeneca, Pfizer/BioNTech |2409975 |126503 |- |2021-04-27 |Oxford/AstraZeneca, Pfizer/BioNTech |2586769 |148282 |- |2021-04-28 |Oxford/AstraZeneca, Pfizer/BioNTech |2808794 |168721 |- |2021-04-29 |Oxford/AstraZeneca, Pfizer/BioNTech |3056004 |198734 |- |2021-04-30 |Oxford/AstraZeneca, Pfizer/BioNTech |3326003 |228399 |- |style="background:#f7faff;"|2021-05-01 |Oxford/AstraZeneca, Pfizer/BioNTech |3395104 |236188 |- |2021-05-02 |Oxford/AstraZeneca, Pfizer/BioNTech |3396864 |236489 |- |2021-05-03 |Oxford/AstraZeneca, Pfizer/BioNTech |3466908 |267032 |- |2021-05-04 |Oxford/AstraZeneca, Pfizer/BioNTech |3530014 |298192 |- |2021-05-05 |Oxford/AstraZeneca, Pfizer/BioNTech |3560324 |323505 |- |2021-05-06 |Oxford/AstraZeneca, Pfizer/BioNTech |3608616 |397190 |- |2021-05-07 |Oxford/AstraZeneca, Pfizer/BioNTech |3662587 |473994 |- |2021-05-08 |Oxford/AstraZeneca, Pfizer/BioNTech |3674682 |501539 |- |2021-05-09 |Oxford/AstraZeneca, Pfizer/BioNTech |3674729 |506274 |- |2021-05-10 |Oxford/AstraZeneca, Pfizer/BioNTech |3692566 |584013 |- |2021-05-11 |Oxford/AstraZeneca, Pfizer/BioNTech |3698657 |664813 |- |2021-05-12 |Oxford/AstraZeneca, Pfizer/BioNTech |3711023 |747707 |- |2021-05-13 |Oxford/AstraZeneca, Pfizer/BioNTech |3719983 |825700 |- |2021-05-14 |Oxford/AstraZeneca, Pfizer/BioNTech |3731221 |905420 |- |2021-05-15 |Oxford/AstraZeneca, Pfizer/BioNTech |3733796 |935357 |- |2021-05-16 |Oxford/AstraZeneca, Pfizer/BioNTech |3733806 |940345 |- |2021-05-17 |Oxford/AstraZeneca, Pfizer/BioNTech |3745934 |1039642 |- |2021-05-18 |Oxford/AstraZeneca, Pfizer/BioNTech |3759058 |1180281 |- |2021-05-19 |Oxford/AstraZeneca, Pfizer/BioNTech |3760940 |1273210 |- |2021-05-20 |Oxford/AstraZeneca, Pfizer/BioNTech |3772599 |1482842 |- |2021-05-21 |Oxford/AstraZeneca, Pfizer/BioNTech |3787570 |1707528 |- |2021-05-22 |Oxford/AstraZeneca, Pfizer/BioNTech |3792660 |1743437 |- |2021-05-23 |Oxford/AstraZeneca, Pfizer/BioNTech |3792906 |1746336 |- |2021-05-24 |Oxford/AstraZeneca, Pfizer/BioNTech |3864784 |1850669 |- |2021-05-25 |Oxford/AstraZeneca, Pfizer/BioNTech |3942775 |1945217 |- |2021-05-26 |Oxford/AstraZeneca, Pfizer/BioNTech |4030744 |2012919 |- |2021-05-27 |Oxford/AstraZeneca, Pfizer/BioNTech |4688520 |2068877 |- |2021-05-28 |Oxford/AstraZeneca, Pfizer/BioNTech |5233963 |2133720 |- |2021-05-29 |Oxford/AstraZeneca, Pfizer/BioNTech |5399015 |2143293 |- |2021-05-30 |Oxford/AstraZeneca, Pfizer/BioNTech |5403854 |2143385 |- |2021-05-31 |Oxford/AstraZeneca, Pfizer/BioNTech |5791503 |2171336 |- |style="background:#f7faff;"|2021-06-01 |Oxford/AstraZeneca, Pfizer/BioNTech |6358512 |2198010 |- |2021-06-02 |Oxford/AstraZeneca, Pfizer/BioNTech |6741993 |2220728 |- |2021-06-03 |Oxford/AstraZeneca, Pfizer/BioNTech |7086292 |2247008 |- |2021-06-04 |Oxford/AstraZeneca, Pfizer/BioNTech |7455726 |2277137 |- |2021-06-05 |Oxford/AstraZeneca, Pfizer/BioNTech |7595072 |2279596 |- |2021-06-06 |Oxford/AstraZeneca, Pfizer/BioNTech |7598787 |2279682 |- |2021-06-07 |Oxford/AstraZeneca, Pfizer/BioNTech |8455799 |2299853 |- |2021-06-08 |Oxford/AstraZeneca, Pfizer/BioNTech |9202346 |2325259 |- |2021-06-09 |Oxford/AstraZeneca, Pfizer/BioNTech |9794163 |2349485 |- |2021-06-10 |Oxford/AstraZeneca, Pfizer/BioNTech, J&J |'''10565404''' |2636135 |- |2021-06-11 |Oxford/AstraZeneca, Pfizer/BioNTech, J&J |11387256 |2873862 |- |2021-06-12 |Oxford/AstraZeneca, Pfizer/BioNTech, J&J |11802287 |2992129 |- |2021-06-13 |Oxford/AstraZeneca, Pfizer/BioNTech, J&J |11830381 |3004029 |- |2021-06-14 |Oxford/AstraZeneca, Pfizer/BioNTech, J&J |12565269 |3262733 |- |2021-06-15 |Oxford/AstraZeneca, Pfizer/BioNTech, J&J |13219207 |3472376 |- |2021-06-16 |Oxford/AstraZeneca, Pfizer/BioNTech, J&J |13790841 |3755040 |- |2021-06-17 |Oxford/AstraZeneca, Pfizer/BioNTech, J&J |14233045 |3884710 |- |2021-06-18 |Oxford/AstraZeneca, Pfizer/BioNTech, J&J |14768365 |4012571 |- |2021-06-19 |Oxford/AstraZeneca, Pfizer/BioNTech, J&J |15012455 |4046611 |- |2021-06-20 |Oxford/AstraZeneca, Pfizer/BioNTech, J&J |15014819 |4047846 |- |2021-06-21 |Ox/AZ, Pf/BNT, J&J, Moderna |15039998 |4167533 |- |2021-06-22 |Ox/AZ, Pf/BNT, J&J, Moderna |15098865 |4292272 |- |2021-06-23 |Ox/AZ, Pf/BNT, J&J, Moderna |15150121 |4413494 |- |2021-06-24 |Ox/AZ, Pf/BNT, J&J, Moderna |15199919 |4521785 |- |2021-06-25 |Ox/AZ, Pf/BNT, J&J, Moderna |15263225 |4618918 |- |2021-06-26 |Ox/AZ, Pf/BNT, J&J, Moderna |15290216 |4643211 |- |2021-06-27 |Ox/AZ, Pf/BNT, J&J, Moderna |15290302 |4643951 |- |2021-06-28 |Ox/AZ, Pf/BNT, J&J, Moderna |15304120 |4758395 |- |2021-06-29 |Ox/AZ, Pf/BNT, J&J, Moderna |15321254 |4905462 |- |2021-06-30 |Ox/AZ, Pf/BNT, J&J, Moderna |15336361 |5041240 |- |} {|class="wikitable" style="width:100%;text-align:center;font-size:10px;line-height:12px;letter-spacing:-0.5px;" |- |Ox/AZ |Oxford/AstraZeneca |- |Pf/BNT |Pfizer/BionNTech |- |J&J |Janssen(Johnson & Johnson) |- |Moderna |Moderna |- |colspan="2"|상기 백신 표기 순서는 접종 개시일 순임. |} ==== 3분기 ==== {|class="wikitable" style="width:100%;text-align:center;font-size:10px;line-height:12px;letter-spacing:-0.5px;" |- !style="background:#013668;color:white;"|날짜 !style="background:#013668;color:white;"|접종 백신 !style="background:#013668;color:white;"|1회차 접종 !style="background:#013668;color:white;"|접종 완료 |- |style="background:#f7faff;min-width:64px;"|2021-07-01 |Ox/AZ, Pf/BNT, J&J, Moderna |15340827 |5156549 |- |2021-07-02 |Ox/AZ, Pf/BNT, J&J, Moderna |15345293 |5271767 |- |2021-07-03 |Ox/AZ, Pf/BNT, J&J, Moderna |15347197 |5319954 |- |2021-07-04 |Ox/AZ, Pf/BNT, J&J, Moderna |15347214 |5321602 |- |2021-07-05 |Ox/AZ, Pf/BNT, J&J, Moderna |15401361 |5368227 |- |2021-07-06 |Ox/AZ, Pf/BNT, J&J, Moderna |15439910 |5463292 |- |2021-07-07 |Ox/AZ, Pf/BNT, J&J, Moderna |15476019 |5553120 |- |2021-07-08 |Ox/AZ, Pf/BNT, J&J, Moderna |15514017 |5654835 |- |2021-07-09 |Ox/AZ, Pf/BNT, J&J, Moderna |15573316 |5801997 |- |2021-07-10 |Ox/AZ, Pf/BNT, J&J, Moderna |15586442 |5871559 |- |2021-07-11 |Ox/AZ, Pf/BNT, J&J, Moderna |15586937 |5873409 |- |2021-07-12 |Ox/AZ, Pf/BNT, J&J, Moderna |15618302 |5940374 |- |2021-07-13 |Ox/AZ, Pf/BNT, J&J, Moderna |15724463 |6058350 |- |2021-07-14 |Ox/AZ, Pf/BNT, J&J, Moderna |15836992 |6183732 |- |2021-07-15 |Ox/AZ, Pf/BNT, J&J, Moderna |15960609 |6326705 |- |2021-07-16 |Ox/AZ, Pf/BNT, J&J, Moderna |16096012 |6507107 |- |2021-07-17 |Ox/AZ, Pf/BNT, J&J, Moderna |16130678 |6563885 |- |2021-07-18 |Ox/AZ, Pf/BNT, J&J, Moderna |16133084 |6565472 |- |2021-07-19 |Ox/AZ, Pf/BNT, J&J, Moderna |16291956 |6613294 |- |2021-07-20 |Ox/AZ, Pf/BNT, J&J, Moderna |16442892 |6684839 |- |2021-07-21 |Ox/AZ, Pf/BNT, J&J, Moderna |16583044 |6723004 |- |2021-07-22 |Ox/AZ, Pf/BNT, J&J, Moderna |16723537 |6779191 |- |2021-07-23 |Ox/AZ, Pf/BNT, J&J, Moderna |16864368 |6847556 |- |2021-07-24 |Ox/AZ, Pf/BNT, J&J, Moderna |16891553 |6858588 |- |2021-07-25 |Ox/AZ, Pf/BNT, J&J, Moderna |16893124 |6858656 |- |2021-07-26 |Ox/AZ, Pf/BNT, J&J, Moderna |17516422 |6917391 |- |2021-07-27 |Ox/AZ, Pf/BNT, J&J, Moderna |17902938 |6972670 |- |2021-07-28 |Ox/AZ, Pf/BNT, J&J, Moderna |18382137 |7018654 |- |2021-07-29 |Ox/AZ, Pf/BNT, J&J, Moderna |18729701 |7061508 |- |2021-07-30 |Ox/AZ, Pf/BNT, J&J, Moderna |19228321 |7131204 |- |2021-07-31 |Ox/AZ, Pf/BNT, J&J, Moderna |19444120 |7145922 |- |style="background:#f7faff;min-width:64px;"|2021-08-01 |Ox/AZ, Pf/BNT, J&J, Moderna |19472376 |7146409 |- |2021-08-02 |Ox/AZ, Pf/BNT, J&J, Moderna |19947507 |7182557 |- |2021-08-03 |Ox/AZ, Pf/BNT, J&J, Moderna |'''20169592''' |7289659 |- |2021-08-04 |Ox/AZ, Pf/BNT, J&J, Moderna |20336252 |7400259 |- |2021-08-05 |Ox/AZ, Pf/BNT, J&J, Moderna |20529566 |7526904 |- |2021-08-06 |Ox/AZ, Pf/BNT, J&J, Moderna |20786192 |7682664 |- |2021-08-07 |Ox/AZ, Pf/BNT, J&J, Moderna |20908244 |7718803 |- |2021-08-08 |Ox/AZ, Pf/BNT, J&J, Moderna |20935989 |7721046 |- |2021-08-09 |Ox/AZ, Pf/BNT, J&J, Moderna |21371194 |7894351 |- |2021-08-10 |Ox/AZ, Pf/BNT, J&J, Moderna |21635106 |8062980 |- |2021-08-11 |Ox/AZ, Pf/BNT, J&J, Moderna |21813171 |8226416 |- |2021-08-12 |Ox/AZ, Pf/BNT, J&J, Moderna |21981720 |8932065 |- |2021-08-13 |Ox/AZ, Pf/BNT, J&J, Moderna |22226384 |9552662 |- |2021-08-14 |Ox/AZ, Pf/BNT, J&J, Moderna |22368941 |9735672 |- |2021-08-15 |Ox/AZ, Pf/BNT, J&J, Moderna |22386973 |9741255 |- |2021-08-16 |Ox/AZ, Pf/BNT, J&J, Moderna |23050358 |9996839 |- |2021-08-17 |Ox/AZ, Pf/BNT, J&J, Moderna |23780511 |'''10491866''' |- |2021-08-18 |Ox/AZ, Pf/BNT, J&J, Moderna |24306127 |10812327 |- |2021-08-19 |Ox/AZ, Pf/BNT, J&J, Moderna |24812397 |11106027 |- |2021-08-20 |Ox/AZ, Pf/BNT, J&J, Moderna |25501990 |11439093 |- |2021-08-21 |Ox/AZ, Pf/BNT, J&J, Moderna |25866970 |11562518 |- |2021-08-22 |Ox/AZ, Pf/BNT, J&J, Moderna |25910685 |11565121 |- |2021-08-23 |Ox/AZ, Pf/BNT, J&J, Moderna |26300189 |12283734 |- |2021-08-24 |Ox/AZ, Pf/BNT, J&J, Moderna |26701704 |12884222 |- |2021-08-25 |Ox/AZ, Pf/BNT, J&J, Moderna |27076636 |13358239 |- |2021-08-26 |Ox/AZ, Pf/BNT, J&J, Moderna |27727639 |13780926 |- |2021-08-27 |Ox/AZ, Pf/BNT, J&J, Moderna |28345045 |14346836 |- |2021-08-28 |Ox/AZ, Pf/BNT, J&J, Moderna |28622306 |14602951 |- |2021-08-29 |Ox/AZ, Pf/BNT, J&J, Moderna |28641079 |14619071 |- |2021-08-30 |Ox/AZ, Pf/BNT, J&J, Moderna |29031142 |15218638 |- |2021-08-31 |Ox/AZ, Pf/BNT, J&J, Moderna |29279112 |15749376 |- |style="background:#f7faff;min-width:64px;"|2021-09-01 |Ox/AZ, Pf/BNT, J&J, Moderna |29458016 |16283360 |- |2021-09-02 |Ox/AZ, Pf/BNT, J&J, Moderna |29644464 |16783832 |- |2021-09-03 |Ox/AZ, Pf/BNT, J&J, Moderna |29877535 |17482977 |- |2021-09-04 |Ox/AZ, Pf/BNT, J&J, Moderna |29996819 |17743649 |- |2021-09-05 |Ox/AZ, Pf/BNT, J&J, Moderna |'''30005459''' |17751820 |- |2021-09-06 |Ox/AZ, Pf/BNT, J&J, Moderna |30747214 |18385936 |- |2021-09-07 |Ox/AZ, Pf/BNT, J&J, Moderna |31323194 |18807546 |- |2021-09-08 |Ox/AZ, Pf/BNT, J&J, Moderna |31709767 |19115022 |- |2021-09-09 |Ox/AZ, Pf/BNT, J&J, Moderna |32149176 |19406809 |- |2021-09-10 |Ox/AZ, Pf/BNT, J&J, Moderna |32800966 |19823479 |- |2021-09-11 |Ox/AZ, Pf/BNT, J&J, Moderna |33130333 |'''20036176''' |- |2021-09-12 |Ox/AZ, Pf/BNT, J&J, Moderna |33152722 |20061878 |- |2021-09-13 |Ox/AZ, Pf/BNT, J&J, Moderna |33979519 |20485521 |- |2021-09-14 |Ox/AZ, Pf/BNT, J&J, Moderna |34582174 |20710283 |- |2021-09-15 |Ox/AZ, Pf/BNT, J&J, Moderna |34977073 |21168093 |- |2021-09-16 |Ox/AZ, Pf/BNT, J&J, Moderna |35414516 |21489009 |- |2021-09-17 |Ox/AZ, Pf/BNT, J&J, Moderna |36075026 |21933023 |- |2021-09-18 |Ox/AZ, Pf/BNT, J&J, Moderna |36467019 |22123396 |- |2021-09-19 |Ox/AZ, Pf/BNT, J&J, Moderna |36505121 |22169798 |- |2021-09-20 |Ox/AZ, Pf/BNT, J&J, Moderna |36527829 |22180500 |- |2021-09-21 |Ox/AZ, Pf/BNT, J&J, Moderna |36542609 |22188840 |- |2021-09-22 |Ox/AZ, Pf/BNT, J&J, Moderna |36570105 |22204741 |- |2021-09-23 |Ox/AZ, Pf/BNT, J&J, Moderna |37132188 |22582280 |- |2021-09-24 |Ox/AZ, Pf/BNT, J&J, Moderna |37749854 |22997770 |- |2021-09-25 |Ox/AZ, Pf/BNT, J&J, Moderna |38064856 |23213814 |- |2021-09-26 |Ox/AZ, Pf/BNT, J&J, Moderna |38091953 |23237917 |- |2021-09-27 |Ox/AZ, Pf/BNT, J&J, Moderna |38511292 |23951629 |- |2021-09-28 |Ox/AZ, Pf/BNT, J&J, Moderna |38769866 |24642525 |- |2021-09-29 |Ox/AZ, Pf/BNT, J&J, Moderna |39002427 |25170260 |- |2021-09-30 |Ox/AZ, Pf/BNT, J&J, Moderna |39347573 |25713009 |} {|class="wikitable" style="width:100%;text-align:center;font-size:10px;line-height:12px;letter-spacing:-0.5px;" |- |Ox/AZ |Oxford/AstraZeneca |- |Pf/BNT |Pfizer/BionNTech |- |J&J |Janssen(Johnson & Johnson) |- |Moderna |Moderna |- |colspan="2"|상기 백신 표기 순서는 접종 개시일 순임. |} ==== 4분기 ==== {|class="wikitable" style="width:100%;text-align:center;font-size:10px;line-height:12px;letter-spacing:-0.5px;" |- !style="background:#013668;color:white;"|날짜 !style="background:#013668;color:white;"|접종 백신 !style="background:#013668;color:white;"|1차 !style="background:#013668;color:white;"|완료 !style="background:#013668;color:white;"|추가 |- |style="background:#f7faff;min-width:64px;"|2021-10-01 |AZ, Pf, J, M |39585265 |26574685 | |- |2021-10-02 |AZ, Pf, J, M |39710470 |26982724 | |- |2021-10-03 |AZ, Pf, J, M |39714000 |27016188 | |- |2021-10-04 |AZ, Pf, J, M |39739505 |27225977 | |- |2021-10-05 |AZ, Pf, J, M |39785657 |27994143 | |- |2021-10-06 |AZ, Pf, J, M |39823981 |28506355 | |- |2021-10-07 |AZ, Pf, J, M |39862414 |29220187 | |- |2021-10-08 |AZ, Pf, J, M |39909124 |'''30322197''' | |- |2021-10-09 |AZ, Pf, J, M |39920919 |30426399 | |- |2021-10-10 |AZ, Pf, J, M |39923747 |30444700 | |- |2021-10-11 |AZ, Pf, J, M |'''40014733''' |30606048 | |- |2021-10-12 |AZ, Pf, J, M |40125204 |31208900 |516 |- |2021-10-13 |AZ, Pf, J, M |40185703 |31625104 |1507 |- |2021-10-14 |AZ, Pf, J, M |40242429 |32083888 |2996 |- |2021-10-15 |AZ, Pf, J, M |40333027 |32810280 |5398 |- |2021-10-16 |AZ, Pf, J, M |40398477 |33166098 |5575 |- |2021-10-17 |AZ, Pf, J, M |40400262 |33185615 |5575 |- |2021-10-18 |AZ, Pf, J, M |40474512 |33818410 |7145 |- |2021-10-19 |AZ, Pf, J, M |40513091 |34265084 |9053 |- |2021-10-20 |AZ, Pf, J, M | | | |- |2021-10-21 |AZ, Pf, J, M | | | |} {|class="wikitable" style="width:100%;text-align:center;font-size:10px;line-height:12px;letter-spacing:-0.5px;" |- |AZ |Oxford/AstraZeneca |- |Pf |Pfizer/BionNTech |- |J |Janssen(Johnson & Johnson) |- |M |Moderna |- |colspan="2"|상기 백신 표기 순서는 접종 개시일 순임. |} === 지역별 접종률 === {|class="wikitable sortable" style="width:100%;text-align:center;font-size:10px;line-height:14px;" |- !style="width:20%;background:#013668;color:white;" rowspan="2"|구분 !style="width:40%;background:#013668;color:white;" colspan="2"|1회차 접종 !style="width:40%;background:#013668;color:white;" colspan="2"|접종 완료 |- !style="width:25%;background:#013668;color:white;"|접종자 !style="width:25%;background:#013668;color:white;"|접종률 !style="width:25%;background:#013668;color:white;"|접종자 !style="width:25%;background:#013668;color:white;"|접종률 |-class="sorttop" |'''합계''' |40400262 |{{#expr: 40400262 / 51671569 * 100 round 2}}% |33185615 |{{#expr: 33185615 / 51671569 * 100 round 2}}% |- |[[서울특별시|'''서울''']] |6105756 |{{#expr: 6105756 / 9558153 * 100 round 2}}% |3675621 |{{#expr: 3675621 / 9558153 * 100 round 2}}% |- |[[부산광역시|'''부산''']] |2181870 |{{#expr: 2181870 / 3361781 * 100 round 2}}% |1355952 |{{#expr: 1355952 / 3361781 * 100 round 2}}% |- |[[대구광역시|'''대구''']] |1483640 |{{#expr: 1483640 / 2395749 * 100 round 2}}% |852607 |{{#expr: 852607 / 2395749 * 100 round 2}}% |- |[[인천광역시|'''인천''']] |1822813 |{{#expr: 1822813 / 2937440 * 100 round 2}}% |1046475 |{{#expr: 1046475/ 2937440 * 100 round 2}}% |- |[[광주광역시|'''광주''']] |910059 |{{#expr: 910059 / 1442482 * 100 round 2}}% |556568 |{{#expr: 556568 / 1442482 * 100 round 2}}% |- |[[대전광역시|'''대전''']] |908240 |{{#expr: 908240 / 1455300 * 100 round 2}}% |528655 |{{#expr: 528655 / 1455300 * 100 round 2}}% |- |[[울산광역시|'''울산''']] |712224 |{{#expr: 712224 / 1125727 * 100 round 2}}% |408286 |{{#expr: 408286 / 1125727 * 100 round 2}}% |- |[[세종특별자치시|'''세종''']] |191758 |{{#expr: 191758 / 364364 * 100 round 2}}% |112508 |{{#expr: 112508 / 364364 * 100 round 2}}% |- |[[경기도|'''경기''']] |8156891 |{{#expr: 8156891 / 13512867 * 100 round 2}}% |4767198 |{{#expr: 4767198 / 13512867 * 100 round 2}}% |- |[[강원도|'''강원''']] |1038684 |{{#expr: 1038684 / 1536140 * 100 round 2}}% |677788 |{{#expr: 677788 / 1536140 * 100 round 2}}% |- |[[충청북도|'''충북''']] |1055205 |{{#expr: 1055205 / 1597501 * 100 round 2}}% |652156 |{{#expr: 652156 / 1597501 * 100 round 2}}% |- |[[충청남도|'''충남''']] |1404014 |{{#expr: 1404014 / 2118205 * 100 round 2}}% |881954 |{{#expr: 881954 / 2118205 * 100 round 2}}% |- |[[전라북도|'''전북''']] |1220276 |{{#expr: 1220276 / 1793902 * 100 round 2}}% |797883 |{{#expr: 797883 / 1793902 * 100 round 2}}% |- |[[전라남도|'''전남''']] |1310073 |{{#expr: 1310073 / 1839698 * 100 round 2}}% |879005 |{{#expr: 879005 / 1839698 * 100 round 2}}% |- |[[경상북도|'''경북''']] |1739341 |{{#expr: 1739341 / 2631649 * 100 round 2}}% |1099282 |{{#expr: 1099282 / 2631649 * 100 round 2}}% |- |[[경상남도|'''경남''']] |2136690 |{{#expr: 2136690 / 3324735 * 100 round 2}}% |1278036 |{{#expr: 1278036 / 3324735 * 100 round 2}}% |- |[[제주특별자치도|'''제주''']] |423432 |{{#expr: 423432 / 675876 * 100 round 2}}% |253505 |{{#expr: 253505 / 675876 * 100 round 2}}% |- |} === 백신 종류별 접종 현황 === {|class="wikitable" style="width:100%;text-align:center;font-size:10px;line-height:14px;" |- !style="background:#013668;color:white;"|접종 개시일 !style="background:#013668;color:white;"|백신 !style="background:#013668;color:white;"|접종 횟수 |- |2021-02-26 |옥스포드/아스트라제네카 |20,248,735 |- |2021-02-27 |화이자/바이오엔테크 |41,645,522 |- |2021-06-15 |모더나 |9,948,843 |- |2021-06-10 |얀센 |1,472,064 |- |colspan="3"|상기 현황은 해당 백신의 총 접종횟수임. |} === 성별, 연령별, 백신별 1차 접종자 현황 === * '''9월 10일 24시 기준''' {|class="wikitable" style="width:100%;text-align:center;font-size:10px;line-height:14px;letter-spacing:-0.5px;" |- !style="width:16%;background:#013668;color:white;" colspan="2" rowspan="2"|구분 !style="width:12%;background:#013668;color:white;" rowspan="2"|인구<ref>'20.12월 행정안전부 주민등록인구현황(거주자) 기준</ref> !style="background:#013668;color:white;" colspan="5"|접종자 !style="width:12%;background:#013668;color:white;" rowspan="2"|인구대비<br>접종률 |- !style="width:12%;background:#013668;color:white;"|누계 !style="width:12%;background:#013668;color:white;"|아스트라제네카 !style="width:12%;background:#013668;color:white;"|화이자 !style="width:12%;background:#013668;color:white;"|모더나 !style="width:12%;background:#013668;color:white;"|얀센 |- |colspan="2"|'''계''' |51,349,116 |32,800,966 |11,092,765 |17,666,614 |2,717,310 |1,324,277 |{{#expr: 32800966 / 51349116 * 100 round 2}}% |- |rowspan="2"|'''성별''' |남성 |25,602,326 |15,877,603 |5,257,211 |8,189,807 |1,320,987 |1,109,598 |{{#expr: 15877603 / 25602326 * 100 round 2}}% |- |여성 |25,746,790 |16,923,363 |5,835,554 |9,476,807 |1,396,323 |214,679 |{{#expr: 16923363 / 25746790 * 100 round 2}}% |- |rowspan="8"|'''연령''' |80세이상 |2,255,736 |1,867,046 |212,031 |1,653,026 |512 |1,477 |{{#expr: 1867046 / 2255736 * 100 round 2}}% |- |70-79 |3,757,129 |3,479,749 |1,923,338 |1,532,685 |14,158 |9,568 |{{#expr: 3479749 / 3757129 * 100 round 2}}% |- |60-69 |7,140,703 |6,674,904 |6,189,522 |351,269 |65,744 |68,369 |{{#expr: 6674904 / 7140703 * 100 round 2}}% |- |50-59 |8,570,076 |7,888,529 |1,022,250 |4,943,782 |1,831,107 |91,390 |{{#expr: 7888529 / 8570076 * 100 round 2}}% |- |40-49 |8,109,221 |4,714,880 |1,014,483 |3,119,245 |309,296 |271,856 |{{#expr: 4714880 / 8109221 * 100 round 2}}% |- |30-39 |6,686,639 |3,826,291 |592,581 |2,151,262 |200,893 |881,555 |{{#expr: 3826291 / 6686639 * 100 round 2}}% |- |18-29 |7,619,756 |4,334,267 |138,560 |3,900,045 |295,600 |62 |{{#expr: 4334267 / 7619756 * 100 round 2}}% |- |17세이하 |7,209,856 |15,300 |0 |15,300 |0 |0 |{{#expr: 15300 / 7209856 * 100 round 2}}% |- |} === 접종 대상자별 접종 현황 === * '''9월 5일 24시 기준''' {|class="wikitable" style="width:100%;text-align:center;font-size:10px;line-height:14px;letter-spacing:-0.5px;" |- !style="background:#013668;color:white;" colspan="2" rowspan="2"|구분 !style="background:#013668;color:white;" colspan="2"|접종대상 현황 !style="background:#013668;color:white;" colspan="2"|접종자 현황 !style="background:#013668;color:white;" colspan="2"|접종률 |- !style="background:#013668;color:white;"|총대상자(A) !style="background:#013668;color:white;"|동의/예약자 !style="background:#013668;color:white;"|1차(B) !style="background:#013668;color:white;"|완료(C) !style="background:#013668;color:white;"|1차(B/A) !style="background:#013668;color:white;"|완료(C/A) |- !style="background:#d6ebfc;" colspan="2"|계 !style="background:#d6ebfc;"|45,486,515 !style="background:#d6ebfc;"|39,446,102 !style="background:#d6ebfc;"|30,005,459 !style="background:#d6ebfc;"|17,751,820 !style="background:#d6ebfc;"|{{#expr: 30005459 / 45486515 * 100 round 2}}% !style="background:#d6ebfc;"|{{#expr: 17751820 / 45486515 * 100 round 2}}% |- |rowspan="23"|위<br>탁<br>의<br>료<br>및<br>접<br>종<br>센<br>터 !style="background:#fcdfd6;"|소계 !style="background:#fcdfd6;"|43,200,382 !style="background:#fcdfd6;"|37,163,997 !style="background:#fcdfd6;"|27,726,909 !style="background:#fcdfd6;"|15,765,944 !style="background:#fcdfd6;"|{{#expr: 27726909 / 43200382 * 100 round 2}}% !style="background:#fcdfd6;"|{{#expr: 15765944 / 43200382 * 100 round 2}}% |- |장애인 돌봄 등<ref>장애인·노인방문·보훈인력 돌봄종사자, 항공승무원</ref>(4.19~) |372,359 |372,358 |372,289 |369,480 |{{#expr: 372289 / 372359 * 100 round 2}}% |{{#expr: 369480 / 372359 * 100 round 2}}% |- |의원급 의료기관 및 약국(4.26~) |252,691 |252,690 |252,630 |250,512 |{{#expr: 252630 / 252691 * 100 round 2}}% |{{#expr: 250512 / 252691 * 100 round 2}}% |- |만성신질환(4.26~) |53,685 |53,683 |53,667 |52,285 |{{#expr: 53667 / 53685 * 100 round 2}}% |{{#expr: 52285 / 53685 * 100 round 2}}% |- |호흡기장애인(5.27~) |5,194 |5,194 |5,190 |5,015 |{{#expr: 5190 / 5194 * 100 round 2}}% |{{#expr: 5015 / 5194 * 100 round 2}}% |- |사회필수인력(4.26~) |169,676 |169,674 |169,493 |168,082 |{{#expr: 169493 / 169676 * 100 round 2}}% |{{#expr: 168082 / 169676 * 100 round 2}}% |- |75세이상(4.1~) |3,394,113 |3,040,196 |3,010,405 |2,947,886 |{{#expr: 3010405 / 3394113 * 100 round 2}}% |{{#expr: 2947886 / 3394113 * 100 round 2}}% |- |60 ~ 74세(5.27~) |8,299,569 |7,517,017 |7,512,272 |6,968,562 |{{#expr: 7512272 / 8299569 * 100 round 2}}% |{{#expr: 6968562 / 8299569 * 100 round 2}}% |- |50 ~ 59세(7.26~) |7,039,349 |6,137,772 |6,122,568 |93,999 |{{#expr: 6137772 / 7039349 * 100 round 2}}% |{{#expr: 6122568 / 7039349 * 100 round 2}}% |- |18 ~ 49세(8.26~) |14,081,345 |10,178,220 |1,198,540 |0 |{{#expr: 1198540 / 14081345 * 100 round 2}}% |{{#expr: 0 / 14081345 * 100 round 2}}% |- |예비군 민방위 등(6.10~) |860,897 |860,047 |860,897 |860,897 |{{#expr: 860897 / 860897 * 100 round 2}}% |{{#expr: 860897 / 860897 * 100 round 2}}% |- |코로나 치료병원(2.27~) |61,025 |61,013 |61,025 |60,885 |{{#expr: 61025 / 61025 * 100 round 2}}% |{{#expr: 60885 / 61025 * 100 round 2}}% |- |노인시설<ref>노인시설 이용·입소자 및 종사자는 아니나 예방접종센터에서 필수목적 출국자 등이 추가 접종된 건 수 포함</ref>(4.1~) |263,703 |257,583 |255,384 |221,480 |{{#expr: 255384 / 263703 * 100 round 2}}% |{{#expr: 221480 / 263703 * 100 round 2}}% |- |2분기 30세 미만<br>AZ 접종제외자(6.15~) |287,858 |287,850 |287,575 |280,573 |{{#expr: 287575 / 287858 * 100 round 2}}% |{{#expr: 280573 / 287858 * 100 round 2}}% |- |6월 초과예약자<ref>60~74세, 호흡기장애인 등</ref>(7.5~) |169,119 |168,765 |166,741 |159,767 |{{#expr: 166741 / 169119 * 100 round 2}}% |{{#expr: 159767 / 169119 * 100 round 2}}% |- |교육 및 보육 종사자<ref>어린이집, 유치원, 초·중등 교직원 등</ref>(7.13~) |886,298 |857,310 |856,772 |702,362 |{{#expr: 856772 / 886298 * 100 round 2}}% |{{#expr: 702362 / 886298* 100 round 2}}% |- |지자체 자율접종(7.13~) |2,264,600 |2,238,653 |1,850,947 |405,575 |{{#expr: 1850947 / 2264600 * 100 round 2}}% |{{#expr: 405575 / 2264600 * 100 round 2}}% |- |고3·고교직원·대입수험생 등<ref>고3 이외 대입수험생 및 대입 관련 종사자 등</ref>(7.19~) |744,573 |727,139 |723,468 |625,538 |{{#expr: 723468 / 744573 * 100 round 2}}% |{{#expr: 625538 / 744573 * 100 round 2}}% |- |발달장애인 등<ref>발달장애인 및 심장·간 등 장애인 및 장애인 직업재활시설 이용자 등</ref>(8.26~) |29,330 |19,775 |15,902 |0 |{{#expr: 15902 / 29330 * 100 round 2}}% |{{#expr: 0 / 29330 * 100 round 2}}% |- |(AZ)기타 대상자<ref>아스트라제네카 예비명단, 접종센터 대상자 중 거동불편자 등</ref>(2.26~) |1,372,025 |1,370,337 |1,366,266 |1,088,526 |{{#expr: 1366266 / 1372025 * 100 round 2}}% |{{#expr: 1088526 / 1372025 * 100 round 2}}% |- |(Pf)기타대상자<ref>예비명단 등</ref>(7.5~) |1,766,261 |1,766,155 |1,763,451 |186,166 |{{#expr: 1763451 / 1766261 * 100 round 2}}% |{{#expr: 186166 / 1766261 * 100 round 2}}% |- |(M)기타대상자<ref>예비명단 등</ref>(7.26~) |529,762 |529,738 |528,920 |25,847 |{{#expr: 528920 / 529762 * 100 round 2}}% |{{#expr: 25847 / 529762 * 100 round 2}}% |- |(J)기타 대상자<ref>얀센 예비명단, 필수목적출국자 등</ref>(6.10~) |296,950 |292,828 |292,507 |292,507 |{{#expr: 292507 / 296950 * 100 round 2}}% |{{#expr: 292507 / 296950 * 100 round 2}}% |- |rowspan="11"|보<br>건<br>소<br>및<br>자<br>체 !style="background:#fcdfd6;"|소계 !style="background:#fcdfd6;"|2,286,133 !style="background:#fcdfd6;"|2,282,105 !style="background:#fcdfd6;"|2,278,550 !style="background:#fcdfd6;"|1,985,876 !style="background:#fcdfd6;"|{{#expr: 2278550 / 2286133 * 100 round 2}}% !style="background:#fcdfd6;"|{{#expr: 1985876 / 2286133 * 100 round 2}}% |- |요양병원(2.26~) |380,942 |380,939 |380,898 |341,631 |{{#expr: 380898 / 380942 * 100 round 2}}% |{{#expr: 341631 / 380942 * 100 round 2}}% |- |요양시설(2.26~) |259,780 |259,780 |259,741 |236,491 |{{#expr: 259741 / 259780 * 100 round 2}}% |{{#expr: 236491 / 259780 * 100 round 2}}% |- |1차 대응요원(2.26~) |129,877 |129,875 |129,877 |126,971 |{{#expr: 129877 / 129877 * 100 round 2}}% |{{#expr: 126971 / 129877 * 100 round 2}}% |- |병원급 이상(3.4~) |478,432 |477,593 |477,590 |458,736 |{{#expr: 477590 / 478432 * 100 round 2}}% |{{#expr: 458736 / 478432 * 100 round 2}}% |- |기타<ref>필수목적 출국자 등</ref> |19,329 |19,329 |18,827 |16,292 |{{#expr: 18827 / 19329 * 100 round 2}}% |{{#expr: 16292 / 19329 * 100 round 2}}% |- |취약시설<ref>장애인·노숙인, 결핵 및 한센인 거주시설, 교정시설 종사자 등</ref>(4.2~) |107,962 |107,962 |107,929 |88,217 |{{#expr: 107929 / 107962 * 100 round 2}}% |{{#expr: 88217 / 107962 * 100 round 2}}% |- |특수교육·보건교사 등(4.2~) |40,468 |39,458 |39,354 |39,015 |{{#expr: 39354 / 40468 * 100 round 2}}% |{{#expr: 39015 / 40468 * 100 round 2}}% |- |사업장 자체접종(7.27~) |307,620 |307,620 |307,381 |149,737 |{{#expr: 307381 / 307620 * 100 round 2}}% |{{#expr: 149737 / 307620 * 100 round 2}}% |- |군 및 입영예정장병(4.28~) |561,723 |559,549 |556,953 |528,786 |{{#expr: 556953 / 561723 * 100 round 2}}% |{{#expr: 528786 / 561723 * 100 round 2}}% |- |} == 백신 공여 == {|class="wikitable" style="width:100%;text-align:center;font-size:10px;line-height:14px;padding:0px;" |- !style="background:#013668;color:white;"|공여일 !style="background:#013668;color:white;"|백신종류 !style="background:#013668;color:white;"|국가 !style="background:#013668;color:white;"|공여규모(회분) |- |2021-10-12 |Oxford/AstraZeneca |베트남 |1,100,000 |- |2021-10-12 |Oxford/AstraZeneca |태국 |470,000 |- |colspan="3"|'''합계''' |'''1,570,000''' |- |colspan="4" style="text-align:left;background:#f7faff;"| |} == 최소 잔여형 주사기(LDS) == === 도입 현황 === 3분기 총 1억개 확보. 3분기 백신도입 예정량(8천만회분) 대비 130% 이상 === 사용 현황 === '''6월 16일 기준''' 절감량(절감률) : 전체 215만회분(15.0%), AZ 137만회분(15.6%), 화이자 67만회분(14.6%), 얀센 10만회분(11.2%) == 각주 == <references/> [[분류:코로나바이러스감염증-19]] 코로나바이러스감염증-19/백신/대한민국 문서로 돌아갑니다.